Influenza hemagglutinin and neuraminidase variants

Carrier of a diamond fine particle for immobilizing virus

Compositions of coronaviruses with a recombination-resistant genome

Prevention of type 1 diabetes and other non-polio enterovirus diseases

Vaccines

Alkyl-glycoside enhanced vaccination

Circovirus sequences associated with piglet weight loss disease (PWD)

Circovirus sequences associated with piglet weight loss disease (PWD)

Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA

Novel post-transcriptional regulatory elements and uses thereof

Delivery vehicles, bioactive substances and viral vaccines

SARS vaccine

Recombinant influenza vectors with tandem transcription units

Recombinant RSV virus expression systems and vaccines

Inactivated FCV vaccines

Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation

Smallpox vaccine

H3 equine influenza A virus

Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA

Stabilization of viral compositions

Modified Vaccinia virus Ankara for the vaccination of neonates

Infectious bursal disease virus (IBDV) variant from Georgia

Cold-adapted equine influenza viruses

Viruses and virus-like particles for multiple antigen and target display

Genetically engineered cell lines and systems for propagating virus and methods of use thereof

Use of sendai virus as a human parainfluenza vaccine

Alphavirus vectors having attentuated virion structural proteins

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

Circovirus sequences associated with piglet weight loss disease (PWD)

Flavivirus variants having phenotypic variation and immunogenic compositions thereof

Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)

Avirulent, immunogenic flavivirus chimeras

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

Microorganisms for therapy

Live attenuated coronavirus vaccines

Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response

Methods and vaccines for providing in ovo protection against turkey rhinotracheitis

Porcine circovirus and Helicobacter combination vaccines and methods of use

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

Attenuated pestiviruses

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes

Immunizing fish against viral infection

Influenza hemagglutinin and neuraminidase variants

Use of vaccinia virus deleted for the E3L gene as a vaccine vector

Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences

Influenza hemagglutinin and neuraminidase variants

Methods of use of viral vectors to deliver antigen to dendritic cells

Infectious DNA as a vaccine against west nile and other flaviviruses

Modified Vaccinia Ankara virus variant

Cellular permissivity factor for viruses and uses thereof

Live organism product

Multi plasmid system for the production of influenza virus

Infectious bursal disease virus antigenic isolates and vaccines

Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same

Recombinant mutants of rhabdovirus and methods of use thereof

Modified vaccinia virus ankara for the vaccination of neonates

Norovirus infected cell cultures and uses therefor

Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E

Prevention of recurrence and metastasis of cancer

Herpes virus vectors for dendritic cells

Peptides selectively lethal to malignant and transformed mammalian cells

Orthopoxvirus vectors, genes and products thereof

Circovirus sequences associated with piglet weight loss disease (PWD)

Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccine

Family of picornaviruses

Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions

Non-spreading pestivirus

Modified Vaccinia Ankara virus variant and cultivation method

Methods of characterizing infectious bursal disease virus

Kits for detecting anti-SIRS antibodies

Replicons of pestviruses that do not express C and or E1 protein and infectious viral particles containing same, that can be used in vaccines

Prostate specific antigen oligoepitope peptide

Immunogenic HIV compositions and related methods

Corona-virus-like particles comprising functionally deleted genomes

DNA transfection system for the generation of infectious influenza virus

Attenuated bovine respiratory syncytial virus

Functional mutations in respiratory syncytial virus

Cold-adapted equine influenza viruses

Chicken anemia virus vaccine from cell line

Recombinant RSV virus expression systems and vaccines

Orthopoxvirus vectors, genes and products thereof

Multi plasmid system for the production of influenza virus

Recombinant RSV virus expression systems and vaccines

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules

Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

Coronavirus-like particles comprising functionally deleted genomes

Sequence analysis of the tetravalent rotavirus vaccine

Virus causing respiratory tract illness in susceptible mammals

Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof

Methods and compositions for treatment and prevention of HSV-2 infections and conditions

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

Attenuated chimeric respiratory syncytial virus

Canine vaccines against Bordetella bronchiseptica

Recombinant RSV virus expression systems and vaccines

Circovirus sequences associated with piglet weight loss disease (PWD)

Escape mutants of newcastle disease virus as marker vaccines

Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains

Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits

Methods and interferon deficient substrates for the propagation of viruses

Virus causing respiratory tract illness in susceptible mammals

West nile virus vaccine

Safe mutant viral vaccines

Immunization with an attenuated human rotavirus

Influenza hemagglutinin and neuraminidase variants

Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making

Microorganisms for therapy

Vaccine

Attenuated HIV strains and uses thereof

Marek's disease virus vaccine

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

Circovirus sequences associated with piglet weight loss disease (PWD)

High titer recombinant influenza viruses for vaccines and gene therapy

Viral marker

Flavivirus vaccines

Attenuated pestiviruses

Conserved region T cell vaccines for coronavirus and methods of use

Methods and compositions for a universal and long-lasting vaccine

Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections

Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms

Conserved region T cell vaccines for coronavirus and methods of use

Systems and methods for generating immune responses in subjects using microchannel delivery devices